|
| |
| | | 69865 | | 28.11.2025 | | Novo Nordisk Pharma AG | | | | | | | 27.11.2030 | | | | | | 07.06.20. | | | | 07.06.20. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Rybelsus N 1.5 mg | Tabletten | Tabletten (Semaglutidum 1.5 mg) | A10BJ06 | PI | | 02 | Rybelsus N 4 mg | Tabletten | Tabletten (Semaglutidum 4 mg) | A10BJ06 | PI | | 03 | Rybelsus N 9 mg | Tabletten | Tabletten (Semaglutidum 9 mg) | A10BJ06 | PI |
|
|
|
